AZD1332 |
AZD1332 : ATP competitive inhibitor of NTRK1 and NTRK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| NTRK1 |
|
|
| NTRK2 |
|
|
Inhibitor
50-100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - FGFR1 24 nM
Selectivity Assessment Description:
In vitro selectivity profiling across a broad panel of 177 kinases (Millipore's Kinase Profiler) sho ...
In Cell Selectivity Assessment
Potency: EC50 - FGFR1 41 nM
Selectivity Assessment Description:
Cell selectivity (EC50): 4077 nM (IGF1R), >1000 nM (Aurora), >3000 (CSF1R), >5000 nM (InsR, Akt, p70 ...
Potency Cellular
In Vitro
NTRK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm800343j
NTRK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm800343j
In Vivo Validations
Rat, Dog
Dose: 3 mg/Kg IV, 10 mg/Kg PO, Reviewer suggest 50-100 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
1.4 (R), 7.5 (D) h
Systemic clearance:
17 (R), 9 (D) mL/min/kg
DOI Reference: 10.1021/jm800343j
Chemical Information
| Molecular Formula | C17H19ClFN7O |
| SMILEs | CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)[nH]n1 |
| InChI | InChI=1S/C17H19ClFN7O/c1-9(2)27-15-6-14(25-26-15)23-16-12(18)8-21-17(24-16)22-10(3)13-5-4-11(19)7-20-13/h4-10H,1-3H3,(H3,21,22,23,24,25,26)/t10-/m0/s1 |
| Molecular weight | 391.13 Da |
| AlogP | 4.091100000000002 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 46 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.